IDEXX Laboratories
Cash Flow
Last updated:
Cash flow statement presents a set of outflows and inflows of cash within a company through operating, investing and financing activities. Over the last year, operating activities of IDEXX Laboratories generated cash of $906,510,000, which is more than the previous year. Cash used in financing activities reached the amount of -$441,996,000 last year. Net change in cash is therefore $341,386,000.
Cash Flow
| 2014 | 235.84M | -80.41M | -103.43M |
|---|---|---|---|
| 2015 | 216.36M | -308.40M | -95.55M |
| 2016 | 334.57M | -90.78M | -217.82M |
| 2017 | 373.27M | -138.68M | -208.01M |
| 2018 | 400.08M | 138.60M | -597.79M |
| 2019 | 459.15M | -205.52M | -286.40M |
| 2020 | 648.06M | -109.37M | -248.41M |
| 2021 | 755.54M | -292.96M | -697.41M |
| 2022 | 542.98M | -195.35M | -370.93M |
| 2023 | 906.51M | -125.25M | -441.99M |
IDXX Cash Flow Statement (2014 – 2023)
| 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | |
|---|---|---|---|---|---|---|---|---|---|---|
Cash at beginning of period | 112.54M | 144.45M | 383.92M | 90.32M | 123.79M | 187.67M | 154.90M | 128.99M | 322.53M | 279.05M |
Operating activities | ||||||||||
Net income | 845.04M | 679.08M | 744.84M | 582.13M | 427.79M | 377.04M | 263.26M | 222.05M | 192.13M | 181.95M |
| Adjustments to reconcile net income to cash generated by operating activities: | ||||||||||
Depreciation and amortization | 114.90M | 111.9M | 104.59M | 95.99M | 88.01M | 83.17M | 83.14M | 78.21M | 68.95M | 58.88M |
Stock-based compensation expense | 59.73M | 49.77M | 37.75M | 30.95M | 39.27M | 0 | 23.51M | 19.89M | 19.88M | 18.09M |
| Deferred income tax benefit | 59.73M | 49.77M | 37.75M | 30.95M | 39.27M | 0 | 23.51M | 19.89M | 19.88M | 18.09M |
| Changes in operating assets and liabilities: | ||||||||||
Accounts receivable, net | -53.87M | -41.39M | -33.14M | -60.72M | -22.47M | -18.40M | -24.91M | -22.55M | -50.14M | -3.62M |
Inventories | -28.65M | -121.73M | -52.91M | -18.88M | -37.30M | -25.62M | -19.06M | 7.64M | -34.96M | -38.31M |
Accounts payable | -557K | 3.46M | 11.23M | 981K | 1.95M | -166K | 1.39M | 2.11M | -2.46M | 6.70M |
Cash generated by operating activities | 906.51M | 542.98M | 755.54M | 648.06M | 459.15M | 400.08M | 373.27M | 334.57M | 216.36M | 235.84M |
Investing activities | ||||||||||
Purchases Of Investments | 0 | -25M | 0 | 0 | 0 | -87K | -334.16M | -227.89M | -271.95M | -5.4M |
Investments In Property Plant And Equipment | -133.63M | -148.83M | -119.54M | -107.62M | -155.22M | -122.93M | -76.70M | -64.78M | -82.92M | -60.69M |
Acquisitions Net | 0 | -46.51M | -173.41M | -1.75M | -50.30M | -22.5M | -14.57M | -1.96M | -10.30M | -19.71M |
Cash generated by investing activities | -125.25M | -195.35M | -292.96M | -109.37M | -205.52M | 138.60M | -138.68M | -90.78M | -308.40M | -80.41M |
Financing activities | ||||||||||
Common Stock Issued | 0 | 0 | 46.56M | 51.32M | 0 | 38.20M | 0 | 38.34M | 0 | 0 |
Payments for dividends | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Repurchases of common stock | -71.92M | -819.71M | -762.33M | -203.41M | -309.71M | -378.69M | -290.63M | -304.08M | -401.98M | -618.15M |
Repayments of term debt | -404M | 430.5M | -50M | -289.62M | -10.27M | -256.04M | 44M | -38M | 274.09M | -1.39M |
Cash used in financing activities | -441.99M | -370.93M | -697.41M | -248.41M | -286.40M | -597.79M | -208.01M | -217.82M | -95.55M | -103.43M |
Net Change In Cash | 341.38M | -31.90M | -239.47M | 293.60M | -33.46M | -63.88M | 32.77M | 25.90M | -193.54M | 43.47M |
Cash at end of period | 453.93M | 112.54M | 144.45M | 383.92M | 90.32M | 123.79M | 187.67M | 154.90M | 128.99M | 322.53M |
| Data source | Data source | Data source | Data source | Data source | Data source | Data source | Data source | Data source | Data source |